First Imported Case of SARS-CoV-2 Omicron Subvariant BA.4 - Guangdong Province, China, May 4, 2022
China CDC Wkly
.
2022 Oct 7;4(40):902-903.
doi: 10.46234/ccdcw2022.095.
Authors
Qianfang Guo
1
,
Changcheng Wu
2
,
Aiping Deng
1
,
Jingtao Liang
3
,
Xiang Zhao
2
,
Ruhan A
2
,
Jiajun Liu
1
,
Fangzhu Ouyang
1
,
Jing Xu
1
,
Shen Huang
1
,
Yang Song
2
,
Lirong Zou
1
,
Xiaoling Deng
1
,
Kai Nie
2
,
Baisheng Li
1
Affiliations
1
Guangdong Provincial Center for Disease Control and Prevention, Guangzhou City, Guangdong Province, China.
2
National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.
3
Foshan Center for Disease Control and Prevention, Foshan City, Guangdong Province, China.
PMID:
36285320
PMCID:
PMC9579979
DOI:
10.46234/ccdcw2022.095
No abstract available
Keywords:
China; Omicron; SARS-CoV-2.